Psoriasis

Featured Article
For Inflammatory Joint and Skin Disease, Switching More Common With Oral Than Injectable Immunotherapy
“Health care resource utilization was higher in the oral group, but total costs were lower,” researchers reported, “which was likely driven by the lower costs of oral drugs.” 
Treatment Class May Worsen Fungal Infections in Patients With Psoriasis
The paper focused on Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 (IL-17) inhibitors.
Major QoL Impairment Possible Among Patients With Lower PASI Scores
Although the minimum eligibility for psoriasis treatment is typically a PASI score of 10 or 12, which is considered moderate psoriasis, patients with lower scores can still have major quality of life…

Newsfeed

For Inflammatory Joint and Skin Disease, Switching More Common With Oral Than Injectable Immunotherapy
Treatment Class May Worsen Fungal Infections in Patients With Psoriasis
Major QoL Impairment Possible Among Patients With Lower PASI Scores
Psoriasis Associated With High Level of Comedication
Hospitalization Predictors of Readmission for Psoriasis
Study Finds Comparable Short-Term Outcomes Among Psoriasis Biologics
Psoriatic Arthritis: A Dermatologist’s Perspective
Insights Into Selecting Biologics for Psoriasis
View More

Insights

Psoriatic Arthritis: A Dermatologist’s Perspective
Alice B. Gottlieb, MD, PhD, clinical professor of dermatology at the Icahn School of Medicine at Mount Sinai in New York, discusses the importance of early identification for patients with psoriatic arthritis as well as treatments that are currently…
Insights Into Selecting Biologics for Psoriasis
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for patients.
Inside the New Psoriasis Guidelines, Part II
Craig A. Elmets, MD, professor of dermatology at the University of Alabama in Birmingham, outlines select recommendations and the role dermatologists play in treating certain conditions.
Inside the New Psoriasis Guidelines, Part I
Alan Menter, MD, chairman of the division of dermatology at Baylor University Medical Center, Dallas, TX, and Craig A. Elmets, MD, professor of dermatology at the University of Alabama in Birmingham and co-chair of the guideline workgroup, provide a…
View More
Back to Top